Fuller & Thaler Asset Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Fuller & Thaler Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$145.72 - $169.96 $72,860 - $84,980	-500 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $121,280 - $141,704	-800 Reduced 61.54%	500 $81,000
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $192,569 - $210,912	1,300	1,300 $198,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.